Terkar Global Financial Development Pvt. Ltd.
Strategic Applications: Corporate Uses of Loan Against Securities
In institutional corporate finance, the decision of how to fund an operational requirement is just as important as the funding amount itself. The diverse structural uses of loan against securities make it a premier tool for business optimization. Operating under our core consulting philosophy, We Don’t Sell, We Solve, the Terkar Capital LAS division ensures that your liquid investment portfolio acts as an active launchpad for enterprise growth, completely bypassing equity dilution or high-premium retail commercial debt.

Primary Corporate & Enterprise Application Matrix
Unlike traditional commercial loans that enforce strict end-use constraints and constant corporate tracking, an asset-backed overdraft line provides total deployment freedom.
-
Immediate Working Capital & Opex Optimization: Companies frequently encounter seasonal cash mismatches, delayed receivables, or sudden vendor obligations. A revolving overdraft line allows CFOs to clear operational costs smoothly without liquidating high-yielding assets or disrupting their core investment path.
-
Accelerated Corporate Capex & Asset Procurement: Funding infrastructure growth, plant expansions, or tech upgrades through standard term structures involves long bureaucratic delays. Leveraging your secondary market portfolio unlocks capital to seize immediate procurement opportunities.
-
Promoter Equity Infusion & Subsidiary Funding: Promoters often need to inject non-dilutive capital into their core operating businesses to support expansion or meet regulatory requirements. An LAS line creates a clean path to route capital back into the enterprise as structured director loans.
-
B2B Supply Chain & Bridge Financing: Secure short-term bridge lines to navigate unexpected contract execution timelines, manage upfront material costs, or fund major corporate transactions while permanent credit files are being structured.
Execution Realities: High-Value Corporate Funding
When deploying capital for advanced business objectives, execution rules must scale to match the transaction size. Below is a direct operational look at how large-ticket corporate syndications (between ₹50 Crore and ₹100 Crore) adjust parameters
2016 Tour Dates | Location | Tickets |
|---|---|---|
Fri., June 20 | The Academy, L.A | Book It |
Thu., June 19 | Bamboo, Santa Barbara | Book It |
Sat., June 28 | Cheers, Santa Cruz | Book It |
Wed., July 6 | The Roxy, San Francisco | Book It |
By understanding these highly flexible uses of loan against securities, your firm can establish a strong, low-cost capital cushion. If your drawn balance remains at zero, your active interest expense is zero. Visit our dedicated portal at loanagainstsecurities.co to review your portfolio's eligibility.